Book a Meeting

Anti-Mouse MGL Monoclonal Antibody (clone ER-MP23) -100 µg (CAT#: CB-P240-AB) Datasheet

Product Type
Antibody
Description
The monoclonal antibody ER-MP23 reacts specifically with macrophage galactose-specific lectin (MGL), a 38 kDa single-chain surface glycoprotein. MGL exists in the connective tissue adjacent to the salivary epithelium. On macrophages, such as salivary glands, lymph node sac MGL is present on the surface of connective tissue macrophages and their bone marrow precursor cells, and MGL is expressed in macrophage cell lines (such as J774-1.6, RAW309Cr.1 and WR19M.1) ) The level of MGL in mature macrophages is increased, and the antigen is co-expressed with the antigen recognized by the monoclonal antibody BM8 (HM1066).
After immunizing rats with a mouse macrophage cell line, monoclonal antibody ER-MP23 was produced. Blocking studies have shown that the monoclonal antibody ER-MP23 can block mouse MGL.
Disease
Infectious diseases
Size
100 µg
Immunogen
Mouse macrophage cell lines
Species
Mouse
Host
Rat
Clonality
Monoclonal
Isotype
Rat IgG2a
Clone Number
ER-MP23
Buffer
PBS, containing 0.1% bovine serum albumin. The endotoxin concentration is < 24 EU/mg, determined with HIT302 LAL Assay.
Application
Flow cytometry, Frozen sections, Functional studies, Paraffin sections
Application Notes
The diluent used depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution. The typical initial working dilution is 1:50.
Storage Instructions
Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year.
Target
MGL
Alternative Names
Macrophage galactose-specific lectin; CD301; dendritic cell-asialoglycoprotein receptor; DC-ASGPR

Related Products

Anti-Mouse MGL Monoclonal Antibody (clone ER-MP23) -0.5 mg (CAT#: CB-P393-AB)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany